GUANGDONG TAIENKANG PHARMACEUTICAL CO., LTD.

Altre lingue Guangdong Taienkang Pharmaceutical Co., Ltd.

Azioni

301263

CNE1000058X0

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 07/06/2024			Variaz. 5gg	Var. 1 gen.
12,99 ^CNY	+2,93%		-5,53%	-20,45%

22/04	Guangdong Taienkang Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
22/04	Guangdong Taienkang Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Guangdong Taienkang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	14/05
Guangdong Taienkang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Guangdong Taienkang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04
Tranche Update on Guangdong Taienkang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.	01/04
Tranche Update on Guangdong Taienkang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.	02/01
Guangdong Taienkang Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	31/10/23
Guangdong Taienkang Pharmaceutical Co., Ltd authorizes a Buyback Plan.	31/10/23
Guangdong Taienkang Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Guangdong Taienkang Pharmaceutical Co., Ltd(XSEC:301263) added to S&P Global BMI Index	18/09/23
BCY Pharm Co., Ltd. announced that it has received CNY 150 million in funding from Guangdong Taienkang Pharmaceutical Co., Ltd	07/09/23
Guangdong Taienkang Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
BCY Pharm Co., Ltd. announced that it expects to receive CNY 150 million in funding from Guangdong Taienkang Pharmaceutical Co., Ltd	25/08/23
Guangdong Taienkang Pharmaceutical Co., Ltd Approves Cash Dividend on A Shares for the Year 2022, Payable on 29 May 2023	19/05/23
Guangdong Taienkang Pharmaceutical Co., Ltd Proposes Final Cash Dividend for 2022	27/04/23
Guangdong Taienkang Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Guangdong Taienkang Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23
Certain A Shares of Guangdong Taienkang Pharmaceutical Co., Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2023.	30/03/23
Taienkang Pharma to Buy 50% of Local Biomedical Firm For 200 Million Yuan	20/02/23
Guangdong Taienkang Pharma to Buy 50% of Local Biomedical Firm For 200 Million Yuan	15/02/23
Guangdong Taienkang Pharmaceutical Co., Ltd entered into an investment agreement to acquire BCY Pharm Co., Ltd from Nanjing Baijiahui Biotechnology Development Co., Ltd and others for CNY 200 million.	14/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guangdong Taienkang Pharmaceutical Co., Ltd.

Azioni

301263

CNE1000058X0

Altre lingue

Filtri